Drug of choice to treat severe fungal infection in AIDS is
**Core Concept**
Fungal infections in immunocompromised patients, such as those with AIDS, are a significant concern due to the potential for severe morbidity and mortality. The treatment of choice for severe fungal infections in these patients involves antifungal medications that can effectively combat the fungal pathogens while minimizing the risk of resistance and adverse effects.
**Why the Correct Answer is Right**
The drug of choice for treating severe fungal infections in AIDS patients is an echinocandin, specifically caspofungin. This antifungal agent works by inhibiting the synthesis of beta-1,3-D-glucan, an essential component of the fungal cell wall. By targeting this critical cell wall component, caspofungin disrupts the structural integrity of the fungal cell, ultimately leading to its death. Caspofungin is particularly effective against Candida species, which are a common cause of fungal infections in immunocompromised patients.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a particular antifungal agent, making it a vague and unhelpful choice.
**Option B:** This option is incorrect because it refers to fluconazole, an azole antifungal that is effective against certain fungal infections but may not be the best choice for severe infections in AIDS patients.
**Option C:** This option is incorrect because it refers to amphotericin B, a polyene antifungal that can be effective against severe fungal infections but may have significant nephrotoxicity and other adverse effects.
**Clinical Pearl / High-Yield Fact**
When treating severe fungal infections in AIDS patients, it is essential to consider the potential for drug interactions and adverse effects, particularly nephrotoxicity and hepatotoxicity. Regular monitoring of liver and kidney function is crucial to minimize these risks and ensure effective treatment.
**Correct Answer: C. Amphotericin B.**